Table 1. Demographic Characteristics of Participants at Baseline.
| Characteristic | Mean (SD) | ||
|---|---|---|---|
| Placebo (n = 33) | Urolithin A (n = 33) | Total (n = 66) | |
| Age, y | 71 (4.58) | 72.5 (5.24) | 71.7 (4.94) |
| Sex, No. (%) | |||
| Female | 23 (69.7) | 27 (81.8) | 50 (75.8) |
| Male | 10 (30.3) | 6 (18.2) | 16 (24.2) |
| White race and ethnicity, No. (%)a | 33 (100) | 33 (100) | 66 (100) |
| BMI | 26.7 (3.77) | 25.7 (3.45) | 26.2 (3.62) |
| Blood pressure | |||
| Systolic, mm Hg | 132.1 (13.03) | 132.9 (13.59) | 132.5 (13.21) |
| Diastolic, mm Hg | 75.5 (7.96) | 76.8 (9.23) | 76.1 (8.57) |
| Heart rate, bpm | 64.4 (9.95) | 65.4 (9.61) | 64.9 (9.72) |
| 6-min Walking distance, m | 464.6 (59.66) | 436.6 (56.26) | 450.6 (59.21) |
| Maximal ATP production, mM/s | 0.703 (0.22) | 0.653 (0.22) | 0.678 (0.20) |
Abbreviations: ATP, adenosine triphosphate; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared).
a
Race and ethnicity were self-reported by participants. All participants identified as White individuals.